About Dr. Cirillo
Jeffrey Cirillo, PhD, is a Regents' professor in the Department of Microbial and Molecular Pathogenesis at the Texas A&M College of Medicine. Dr. Cirillo's research interests are in the pathogenesis of bacterial lung infections including tuberculosis, Legionnaires' disease and other pneumonia agents, and he has been a tuberculosis researcher for more than 30 years. His team utilizes both animal and molecular models to understand airborne pathogens and to develop novel prevention, treatment and diagnostic strategies to improve global health.
Dr. Cirillo leads the Center for Airborne Pathogens Research and Tuberculosis Image Resources (CAPRI) formed in 2007 and the Small Animal Model Vaccines and Pathogenesis (SAMVAP) group. He has been awarded over $5 million from the Bill & Melinda Gates Foundation's Global Health Program and currently has over $1 million from NIH, supporting his work on real-time optical imaging and detection of tuberculosis, and is currently involved in numerous collaborative projects.
Dr. Cirillo previously held faculty positions at the University of Hawaii and University of Nebraska. He has published more than 100 manuscripts and obtained funding from the National Institutes of Health, American Lung Association, U.S. Department of Agriculture and several private foundations and commercial entities. He has extensive experience reviewing research in respiratory infectious diseases for journals and is on the editorial boards for several infectious disease journals.
Dr. Cirillo received his Bachelor of Arts from Pitzer College, Master of Science and doctorate degree from Albert Einstein College of Medicine. He also completed postdoctoral research at Stanford University School of Medicine.
Vital Record news coverage
Spotting even the smallest tuberculosis infections to save even the tiniest patients
How Texas A&M researchers are developing new ways of detecting infection that might be especially helpful in children
October 3, 2016
Looking at the bacteria inside: A new method of viewing TB bacteria
Researchers have developed a new method that will help them quickly determine the effectiveness of a TB treatment
March 23, 2016